These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5567802)

  • 21. The effect of noradrenaline and phenoxybenzamine on the renal response to hemorrhage.
    Bell G; Lister GD
    Surg Gynecol Obstet; 1970 May; 130(5):813-20. PubMed ID: 5440767
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of lysosomal hydrolases in the mechanism of shock.
    Smith JJ; Loegering DJ; McDermott DJ; Bonin ML
    Adv Exp Med Biol; 1972; 33(0):535-43. PubMed ID: 4672023
    [No Abstract]   [Full Text] [Related]  

  • 23. Protective action of a protease inhibitor in hemorrhagic shock.
    Glenn TM; Herlihy BL; Lefer AM
    Arch Int Pharmacodyn Ther; 1973 Jun; 203(2):292-304. PubMed ID: 4542687
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of corticosteroid treatment on renal blood flow in hemorrhagic shock.
    Nagy S; Barankay T; Horpácsy G
    Eur Surg Res; 1970; 2(5):333-40. PubMed ID: 5527868
    [No Abstract]   [Full Text] [Related]  

  • 25. Spleen as an experimental model for the study of vascular capacitance.
    Opdyke DF; Ward CJ
    Am J Physiol; 1973 Dec; 225(6):1416-20. PubMed ID: 4760454
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of corticosteroid treatment on splanchnic blood flow in hemorrhagic shock.
    Nagy S; Barankay T; Horpácsy G; Petri G
    Eur Surg Res; 1970; 2(4):263-8. PubMed ID: 5527867
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of some autonomic drugs on the uric acidemia of hemorrhagic shock.
    Cowsert MK; Carrier O
    Can J Physiol Pharmacol; 1967 Jan; 45(1):169-72. PubMed ID: 6030394
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of lysosomes in the pathogenesis of splanchnic ischemia shock in cats.
    Glenn TM; Lefer AM
    Circ Res; 1970 Nov; 27(5):783-97. PubMed ID: 5486246
    [No Abstract]   [Full Text] [Related]  

  • 29. Interest of isoproterenol in the treatment of hemorrhagic shock in dogs.
    Rettmann R; de Muylder C
    Eur Surg Res; 1976; 8(4):321-36. PubMed ID: 8316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of phosphodiesterase inhibitor on the fragility of lysosomal enzymes in hemorrhagic shock].
    Ishizaki K
    Masui; 1983 Jul; 32(7):785-92. PubMed ID: 6632179
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonventilatory benefits of respiratory support during irreversible hemorrhagic shock.
    Lewis JD; Itskovitz HD; Brown JR; Darin JC
    Surg Forum; 1974; 25(0):12-4. PubMed ID: 4474712
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of a myocardial depressant factor in the pathogenesis of circulatory shock.
    Lefer AM
    Fed Proc; 1970; 29(6):1836-47. PubMed ID: 5482718
    [No Abstract]   [Full Text] [Related]  

  • 33. Prostaglandin E1 as a therapeutic agent in hemorrhagic shock.
    Machiedo GW; Brown CS; Lavigne JE; Rush BF
    Surg Forum; 1973; 24():12-4. PubMed ID: 4805962
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of severity and duration of hemorrhagic hypotension and the narcosis on the plasma levels of lysosomal enzymes in dogs (author's transl)].
    Horpácsy G; Gergely M; Barankay T; Hézsai K
    Res Exp Med (Berl); 1975; 165(1):23-30. PubMed ID: 1138317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications for adrenergic stimulators in shock.
    Mills LC; Moyer JH
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamic effects of isoproterenol and noradrenalin in experimental shock.
    Dedichen H; Schenk WG
    Acta Chir Scand; 1973; 139(3):213-8. PubMed ID: 4698482
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antishock effect of gabexate mesilate (FOY).
    Oda T; Miyawaki T; Sameshima T; Miyao J; Arai Y; Yoshimine K; Yoshimura N
    Prog Clin Biol Res; 1983; 111():293-307. PubMed ID: 6408649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation-induced alterations in serum and splenic lysosomal hydrolases of rat.
    Snyder SL
    Radiat Res; 1977 Feb; 69(2):306-16. PubMed ID: 841005
    [No Abstract]   [Full Text] [Related]  

  • 40. Lysosomal enzyme release in canine endotoxin shock treated with methylprednisolone.
    Warren HS; Ferguson WW; Wangensteen SL
    Am Surg; 1973 Nov; 39(11):608-18. PubMed ID: 4583541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.